141.715 USD
+0.03 (+0.02%)
Taking everything into account, MASI scores 4 out of 10 in our fundamental rating. MASI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. MASI has an average financial health and profitability rating. MASI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MASI was profitable.
MASI had a positive operating cash flow in the past year.
Of the past 5 years MASI 4 years were profitable.
MASI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
MASI has a Return On Assets of -31.33%. This is comparable to the rest of the industry: MASI outperforms 42.25% of its industry peers.
MASI has a Return On Equity (-70.30%) which is in line with its industry peers.
With an excellent Return On Invested Capital value of 9.63%, MASI belongs to the best of the industry, outperforming 88.77% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MASI is below the industry average of 8.81%.
The last Return On Invested Capital (9.63%) for MASI is above the 3 year average (4.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| ROIC | 9.63% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
1.3 Margins
MASI has a better Operating Margin (10.29%) than 79.14% of its industry peers.
In the last couple of years the Operating Margin of MASI has declined.
Looking at the Gross Margin, with a value of 54.96%, MASI is in line with its industry, outperforming 52.94% of the companies in the same industry.
MASI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.29% | ||
| PM (TTM) | N/A | ||
| GM | 54.96% |
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MASI is still creating some value.
MASI has more shares outstanding than it did 1 year ago.
MASI has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for MASI has been reduced compared to a year ago.
2.2 Solvency
MASI has an Altman-Z score of 7.22. This indicates that MASI is financially healthy and has little risk of bankruptcy at the moment.
MASI has a better Altman-Z score (7.22) than 85.56% of its industry peers.
MASI has a debt to FCF ratio of 2.96. This is a good value and a sign of high solvency as MASI would need 2.96 years to pay back of all of its debts.
MASI's Debt to FCF ratio of 2.96 is amongst the best of the industry. MASI outperforms 84.49% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that MASI is somewhat dependend on debt financing.
MASI has a worse Debt to Equity ratio (0.69) than 66.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.96 | ||
| Altman-Z | 7.22 |
ROIC/WACC1.16
WACC8.28%
2.3 Liquidity
MASI has a Current Ratio of 2.84. This indicates that MASI is financially healthy and has no problem in meeting its short term obligations.
MASI has a Current ratio (2.84) which is comparable to the rest of the industry.
MASI has a Quick Ratio of 1.92. This is a normal value and indicates that MASI is financially healthy and should not expect problems in meeting its short term obligations.
MASI has a Quick ratio (1.92) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.77% over the past year.
MASI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.86% yearly.
MASI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.03%.
Measured over the past years, MASI shows a quite strong growth in Revenue. The Revenue has been growing by 17.43% on average per year.
EPS 1Y (TTM)54.77%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%34.69%
Revenue 1Y (TTM)-16.03%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-26.44%
3.2 Future
Based on estimates for the next years, MASI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.11% on average per year.
Based on estimates for the next years, MASI will show a decrease in Revenue. The Revenue will decrease by -1.10% on average per year.
EPS Next Y30.61%
EPS Next 2Y18.16%
EPS Next 3Y16%
EPS Next 5Y12.11%
Revenue Next Year-27.11%
Revenue Next 2Y-11.76%
Revenue Next 3Y-5.74%
Revenue Next 5Y-1.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.95 indicates a rather expensive valuation of MASI.
Compared to the rest of the industry, the Price/Earnings ratio of MASI indicates a somewhat cheap valuation: MASI is cheaper than 79.14% of the companies listed in the same industry.
MASI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.49.
With a Price/Forward Earnings ratio of 23.71, MASI is valued on the expensive side.
75.94% of the companies in the same industry are more expensive than MASI, based on the Price/Forward Earnings ratio.
MASI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.95 | ||
| Fwd PE | 23.71 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MASI is valued a bit cheaper than 71.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MASI is valued a bit cheaper than 75.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.34 | ||
| EV/EBITDA | 33.81 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MASI's earnings are expected to grow with 16.00% in the coming years.
PEG (NY)0.82
PEG (5Y)4.26
EPS Next 2Y18.16%
EPS Next 3Y16%
5. Dividend
5.1 Amount
MASI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:MASI (12/8/2025, 10:38:53 AM)
141.715
+0.03 (+0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners106.84%
Inst Owner Change-2.71%
Ins Owners0.19%
Ins Owner Change1.07%
Market Cap7.61B
Revenue(TTM)1.72B
Net Income(TTM)-569.40M
Analysts81.25
Price Target186.13 (31.34%)
Short Float %7.55%
Short Ratio5.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.18%
Min EPS beat(2)6.64%
Max EPS beat(2)7.73%
EPS beat(4)4
Avg EPS beat(4)9.88%
Min EPS beat(4)6.64%
Max EPS beat(4)14.9%
EPS beat(8)8
Avg EPS beat(8)11.58%
EPS beat(12)12
Avg EPS beat(12)9.84%
EPS beat(16)16
Avg EPS beat(16)9.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.35%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-1.35%
Max Revenue beat(4)-0.59%
Revenue beat(8)0
Avg Revenue beat(8)-1.1%
Revenue beat(12)1
Avg Revenue beat(12)-1.81%
Revenue beat(16)4
Avg Revenue beat(16)-1.23%
PT rev (1m)-1.72%
PT rev (3m)-2.48%
EPS NQ rev (1m)-0.08%
EPS NQ rev (3m)2.06%
EPS NY rev (1m)2.74%
EPS NY rev (3m)2.84%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.95 | ||
| Fwd PE | 23.71 | ||
| P/S | 4.44 | ||
| P/FCF | 40.34 | ||
| P/OCF | 36.63 | ||
| P/B | 9.4 | ||
| P/tB | 11.67 | ||
| EV/EBITDA | 33.81 |
EPS(TTM)5.68
EY4.01%
EPS(NY)5.98
Fwd EY4.22%
FCF(TTM)3.51
FCFY2.48%
OCF(TTM)3.87
OCFY2.73%
SpS31.93
BVpS15.08
TBVpS12.15
PEG (NY)0.82
PEG (5Y)4.26
Graham Number43.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| ROCE | 12.18% | ||
| ROIC | 9.63% | ||
| ROICexc | 12.27% | ||
| ROICexgc | 14.25% | ||
| OM | 10.29% | ||
| PM (TTM) | N/A | ||
| GM | 54.96% | ||
| FCFM | 11% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
ROICexc(3y)5.01%
ROICexc(5y)12.81%
ROICexgc(3y)9.36%
ROICexgc(5y)17.94%
ROCE(3y)5.86%
ROCE(5y)10.38%
ROICexgc growth 3Y-54.41%
ROICexgc growth 5Y-39.37%
ROICexc growth 3Y-57.67%
ROICexc growth 5Y-43.42%
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
F-Score6
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.96 | ||
| Debt/EBITDA | 2.41 | ||
| Cap/Depr | 34.11% | ||
| Cap/Sales | 1.11% | ||
| Interest Coverage | 5.14 | ||
| Cash Conversion | 89.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 7.22 |
F-Score6
WACC8.28%
ROIC/WACC1.16
Cap/Depr(3y)60.07%
Cap/Depr(5y)110.25%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.77%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%34.69%
EPS Next Y30.61%
EPS Next 2Y18.16%
EPS Next 3Y16%
EPS Next 5Y12.11%
Revenue 1Y (TTM)-16.03%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-26.44%
Revenue Next Year-27.11%
Revenue Next 2Y-11.76%
Revenue Next 3Y-5.74%
Revenue Next 5Y-1.1%
EBIT growth 1Y9.5%
EBIT growth 3Y-45.85%
EBIT growth 5Y-27.67%
EBIT Next Year41.92%
EBIT Next 3Y17.03%
EBIT Next 5Y13.17%
FCF growth 1Y423.12%
FCF growth 3Y-14.18%
FCF growth 5Y-0.52%
OCF growth 1Y1898.08%
OCF growth 3Y-9.48%
OCF growth 5Y-2.39%
MASIMO CORP / MASI FAQ
What is the fundamental rating for MASI stock?
ChartMill assigns a fundamental rating of 4 / 10 to MASI.
What is the valuation status for MASI stock?
ChartMill assigns a valuation rating of 4 / 10 to MASIMO CORP (MASI). This can be considered as Fairly Valued.
Can you provide the profitability details for MASIMO CORP?
MASIMO CORP (MASI) has a profitability rating of 4 / 10.
What is the financial health of MASIMO CORP (MASI) stock?
The financial health rating of MASIMO CORP (MASI) is 6 / 10.
How sustainable is the dividend of MASIMO CORP (MASI) stock?
The dividend rating of MASIMO CORP (MASI) is 0 / 10 and the dividend payout ratio is 0%.